MediWound Ltd.(MDWD)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,569 of 2,960 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
MDWD Stock Analysis & AI Quality Score
Data updated 2026-09-12AI stock analysis and institutional research for MediWound Ltd. (MDWD), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores MDWD at 28.0/100 on a 32-signal composite quality model, placing it at rank #2,569 of 2,960 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (FY 2025), MediWound Ltd. reports quarterly revenue of $17.0M, net income of $-23.9M. Top institutional holders of MDWD by reported 13-F value include INVESTOR AB, Yelin Lapidot Management Ltd., Rosalind Advisors, based on the most recent SEC filings. MDWD trades on the Nasdaq exchange and files with the SEC under CIK 1593984. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MDWD daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for MediWound Ltd. directly from SEC EDGAR.
Revenue
FY 2025
$17.0M
Net Income
FY 2025
$-23.9M
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · ProRevenue
-16.1% YoYTotal Assets
+17.4% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $17.0M -16.1% | $20.2M +8.2% | $18.7M -29.5% | $26.5M +11.5% | $23.8M +9.2% | $21.8M |
| Total Assets | $86.3M +17.4% | $73.5M +10.6% | $66.5M +32.9% | $50.0M +153.3% | $19.7M -36.5% | $31.1M |
Get alerted when MDWD's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for MediWound Ltd. including:
Top Institutional Holders of MDWD
INVESTOR AB
$12.8M872,093 shYelin Lapidot Holdings Management Ltd.
$11.1M758,169 shRosalind Advisors, Inc.
$11.0M749,054 shPRICE T ROWE ASSOCIATES INC /MD/
$9.4M641,075 shBlackRock, Inc.
$7.7M525,929 shSPHERA FUNDS MANAGEMENT LTD.
$4.0M273,192 shSilverberg Bernstein Capital Management LLC
$3.4M228,137 shSTATE STREET CORP
$2.5M168,669 shUBS Group AG
$2.3M155,922 shGEODE CAPITAL MANAGEMENT, LLC
$2.1M141,041 sh
| Fund | Value | Shares |
|---|---|---|
| INVESTOR AB | $12.8M | 872,093 |
| Yelin Lapidot Holdings Management Ltd. | $11.1M | 758,169 |
| Rosalind Advisors, Inc. | $11.0M | 749,054 |
| PRICE T ROWE ASSOCIATES INC /MD/ | $9.4M | 641,075 |
| BlackRock, Inc. | $7.7M | 525,929 |
| SPHERA FUNDS MANAGEMENT LTD. | $4.0M | 273,192 |
| Silverberg Bernstein Capital Management LLC | $3.4M | 228,137 |
| STATE STREET CORP | $2.5M | 168,669 |
| UBS Group AG | $2.3M | 155,922 |
| GEODE CAPITAL MANAGEMENT, LLC | $2.1M | 141,041 |
More Healthcare Companies
View all Healthcare →Put MDWD on your watchlist
Track score changes the day MediWound Ltd. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is MDWD a good stock to buy?
13F Pro's AI-powered analysis of MediWound Ltd. (MDWD) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for MDWD are available on the MDWD stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. MDWD is classified as a small company.
Which hedge funds own MDWD?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling MDWD. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of MediWound Ltd.'s investment landscape.